Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of -4139.38% is in line with its 5-year average of -4575.81%, near the high end of its 5-year range (-18412.71%–-24.83%).
57.42% above its 12-month average of -9720.60%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): -18412.71%.
NET PROFIT MARGIN
-4139.38%
NET PROFIT MARGIN AVG TTM
-9720.60%
NET PROFIT MARGIN AVG 3Y
-7109.36%
NET PROFIT MARGIN AVG 5Y
-4575.81%
NET PROFIT MARGIN AVG 10Y
N/A
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+57.42%
CURRENT VS 3Y AVG
+41.78%
CURRENT VS 5Y AVG
+9.54%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-0.06%
median of 809 covered companies
CURRENT VS SECTOR MEDIAN
-6898866.67%
vs the sector median at left
Nexalin Technology, Inc.
Market Cap
$3.57M
Net Profit Margin
-4139.38%
TTM Avg
-9720.60%
3Y Avg
-7109.36%
5Y Avg
-4575.81%
Market Cap
$3.44M
Net Profit Margin
-105.71%
TTM Avg
-81.70%
3Y Avg
-1471.40%
5Y Avg
-1177.12%
Market Cap
$3.42M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$3.79M
Net Profit Margin
-694.19%
TTM Avg
-257.90%
3Y Avg
-726.73%
5Y Avg
-1357.15%
Market Cap
$3.32M
Net Profit Margin
-87.20%
TTM Avg
-5303.47%
3Y Avg
-2728.60%
5Y Avg
-1828.05%
Market Cap
$3.26M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
-523.72%
5Y Avg
-1138.73%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Nexalin Technology, Inc. (NXL) | $3.57M | -4139.38% | -9720.60% | -7109.36% | -4575.81% |
| Eocene Ltd. (EOCN)vs › | $3.54M | N/A | N/A | N/A | N/A |
| Mustang Bio, Inc. (MBIO)vs › | $3.49M | 0.00% | 0.00% | 0.00% | 0.00% |
| Moolec Science S.A. (MLEC)vs › | $3.44M | -105.71% | -81.70% | -1471.40% | -1177.12% |
| Cadrenal Therapeutics, Inc. Common Stock (CVKD)vs › | $3.42M | 0.00% | 0.00% | 0.00% | 0.00% |
| Evogene Ltd. (EVGN)vs › | $3.79M | -694.19% | -257.90% | -726.73% | -1357.15% |
| Paranovus Entertainment Technology Ltd. (PAVS)vs › | $3.32M | -87.20% | -5303.47% | -2728.60% | -1828.05% |
| Aethlon Medical, Inc. (AEMD)vs › | $3.26M | 0.00% | 0.00% | -523.72% | -1138.73% |
| MBody AI Ltd. (MBAI)vs › | $3.17M | 0.00% | 0.00% | 0.00% | 0.00% |
| IceCure Medical Ltd (ICCM)vs › | $3.13M | -427.67% | -455.53% | -478.79% | -375.12% |
Operating Margin
-2781.7%
Net Profit Margin
-4139.4%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | -18412.71% |
| 2026-03-31 | -14025.67% |
| 2025-12-31 | -1382.56% |
| 2025-09-30 | -12542.35% |
| 2025-06-30 | -2239.74% |
| 2025-03-31 | -4847.83% |
| 2024-12-31 | -10424.50% |
| 2024-09-30 | -6794.86% |
| 2024-06-30 | -4785.74% |
| 2024-03-31 | -1323.43% |
| 2023-12-31 | -3801.47% |
| 2023-09-30 | -9526.77% |
| 2023-06-30 | -2314.12% |
| 2023-03-31 | -2449.00% |
| 2022-12-31 | -1899.01% |
| 2022-09-30 | -24.83% |
| 2022-06-30 | -111.61% |
| 2022-03-31 | -121.63% |
| 2021-12-31 | -2483.14% |
| 2021-09-30 | -3215.49% |
| 2021-06-30 | -7202.45% |
| 2021-03-31 | -4529.20% |
| 2020-12-31 | -1406.87% |
| 2020-09-30 | -2052.34% |
| 2020-06-30 | -1261.52% |
| 2020-03-31 | -1261.51% |
